Correlation Between Cadrenal Therapeutics, and Third Harmonic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Third Harmonic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Third Harmonic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Third Harmonic Bio, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Third Harmonic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Third Harmonic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Third Harmonic.

Diversification Opportunities for Cadrenal Therapeutics, and Third Harmonic

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cadrenal and Third is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Third Harmonic Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Third Harmonic Bio and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Third Harmonic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Third Harmonic Bio has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Third Harmonic go up and down completely randomly.

Pair Corralation between Cadrenal Therapeutics, and Third Harmonic

Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 1.07 times more return on investment than Third Harmonic. However, Cadrenal Therapeutics, is 1.07 times more volatile than Third Harmonic Bio. It trades about -0.04 of its potential returns per unit of risk. Third Harmonic Bio is currently generating about -0.08 per unit of risk. If you would invest  1,509  in Cadrenal Therapeutics, Common on August 28, 2024 and sell it today you would lose (153.00) from holding Cadrenal Therapeutics, Common or give up 10.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cadrenal Therapeutics, Common  vs.  Third Harmonic Bio

 Performance 
       Timeline  
Cadrenal Therapeutics, 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.
Third Harmonic Bio 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Third Harmonic Bio are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Third Harmonic may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Cadrenal Therapeutics, and Third Harmonic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cadrenal Therapeutics, and Third Harmonic

The main advantage of trading using opposite Cadrenal Therapeutics, and Third Harmonic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Third Harmonic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Third Harmonic will offset losses from the drop in Third Harmonic's long position.
The idea behind Cadrenal Therapeutics, Common and Third Harmonic Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments